Functional & Integrative Psychiatry for Children, Teens, & Y

---

We incorporate advanced tools such as pharmacogenomics testing, functional laboratory testing, and specialized testing of nutrient levels and the gut microbiome. These insights, combined with cognitive behavioral therapy and emerging digital therapeutics, enable us to develop highly personalized treatment plans tailored to each child’s unique needs. 

Our goal is to address the root causes of mental health concerns, supporting not only symptom improvement but also the child’s overall wellbeing and long-term development.

Cognitive Function Development Therapy (CFDT) is a neuroscience-based treatment modality that aims to address brain imbalances by promoting the reallocation of neural resources for desired far-reaching transference effects. Integrating principles from cognitive behavioral therapy, CFDT utilizes objective assessments of primary cognitive functions to direct treatment, targeting lower functions to facilitate cognitive resource development and enhance overall nervous system adaptability. 

Additionally, CFD therapy incorporates elements of digital therapeutics, employing dynamically interactive activities presented in either competitive or collaborative formats to stimulate the targeted neuroplastic remodeling. Outcomes of this approach include a reduction or elimination of dependence on medications, successful completion of traditional therapies, and accomplishments that extend beyond clinical success, such as improved relationships and enhanced academic or vocational performance. Pharmacogenomics testing may also help personalize treatment and further optimize the therapeutic process.

Many factors influence a patient’s treatment and response to medications. Pharmacogenomics testing (PGx) is an objective component to provide personalized treatment and improve clinical outcomes, enhancing approaches like cognitive behavioral therapy and digital therapeutics.

Pharmacogenomic tests inform medication selection and dosing for patients experiencing depression, anxiety, ADHD, and other mental health conditions.

Your patient’s PGx results are part of a comprehensive, data-driven platform designed to empower you to offer precision mental health care.

Digital therapeutics in psychiatry leverage tools like mobile apps, web platforms, and wearable integrations to provide structured treatments, including cognitive behavioral therapy (CBT), cognitive training and remediation, symptom tracking with real-time feedback, behavioral activation, psychoeducation, and medication adherence support. Some digital therapeutics used in psychiatric care are not only U.S. Food and Drug Administration-approved but also clinically validated. Additionally, pharmacogenetic testing may enhance the personalization of care. Feel free to reach out if you have any questions or would like to learn more about how these innovative tools, including cognitive behavioral therapy, may support your treatment journey.